Publications by authors named "Elena A Turkevich"

Background: As endometrial cancer (EC) prevalence increases with obesity, we aimed to determine whether EC characteristics depend upon obesity type: 'standard' (SO) or 'metabolically healthy obesity' (MHO).

Patients & Methods: 258 EC patients were included. Data on anthropometry, blood hormones, lipids and glucose, and tumor features were collected.

View Article and Find Full Text PDF

The BLM gene belongs to the RecQ helicase family and has been implicated in the maintenance of genomic stability. Its homozygous germline inactivation causes Bloom syndrome, a severe genetic disorder characterized by growth retardation, impaired fertility and highly elevated cancer risk. We hypothesized that BLM is a candidate gene for breast cancer (BC) predisposition.

View Article and Find Full Text PDF
Article Synopsis
  • The coexistence of type 2 diabetes with breast cancer can negatively impact survival rates, potentially due to changes in tumor hormone sensitivity.
  • Previous studies have noted alterations in breast tumor receptor status among diabetic patients, yet often overlook the type of diabetes treatment received.
  • This analysis of receptor status in 90 postmenopausal women indicated that those treated with metformin had a higher occurrence of progesterone receptor-positive tumors compared to those treated only with sulfonylureas or insulin, highlighting the need to consider diabetes treatment types when examining cancer outcomes.
View Article and Find Full Text PDF

Amplification of HER2, C-MYC and CCND1 oncogenes is a hallmark of breast cancer (BC); however, its involvement in the bilateral form of this disease has not been investigated yet. In this study, 50 bilateral BC (biBC) pairs (100 tumors) and 72 control unilateral BC were examined using real-time PCR analysis of microdissected archival tissues. In biBC, the frequency of >3-fold oncogene amplification was 6/100 (6%) for HER2, 6/100 (6%) for C-MYC and 7/100 (7%) for CCND1.

View Article and Find Full Text PDF

The gene for Nijmegen chromosomal breakage syndrome (NBS1) plays a role in a variety of processes protecting chromosomal stability. Recently, it was suggested in a Polish case-control study that the founder hypomorphic mutation in NBS1, 657del5, which occurs in approximately 0.5% of Slavic subjects, may be associated with an increased risk of breast cancer (BC).

View Article and Find Full Text PDF

Bilateral breast cancer (biBC) is a common form of breast cancer; however, it has not been subjected to systematic comparative genetic studies. We allelotyped 28 biBCs on 14 chromosomal arms, addressing 2 lines of questions: (i) does comparison of genetic profiles disclose contralateral metastases misdiagnosed as second primaries? and (ii) do shared environmental and host factors drive the development of true biBC along similar genetic routes? Allelotyping provided unambiguous proof for distinct clonality in 23 of 28 cases. In another 4 biBCs, the genotyping data did not exclude the hypothesis of metastatic spread, whereas clinical and histologic data were in favor of bilaterality.

View Article and Find Full Text PDF